Craig Bijou
Stock Analyst at B of A Securities
(3.75)
# 738
Out of 5,113 analysts
66
Total ratings
58.33%
Success rate
53.02%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Craig Bijou
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GEHC GE HealthCare Technologies | Maintains: Neutral | $82 → $92 | $79.77 | +15.33% | 3 | Jan 5, 2026 | |
| PRCT PROCEPT BioRobotics | Downgrades: Neutral | $55 → $38 | $29.13 | +30.45% | 5 | Dec 8, 2025 | |
| GMED Globus Medical | Upgrades: Buy | $65 → $91 | $92.52 | -1.64% | 5 | Nov 7, 2025 | |
| RXST RxSight | Maintains: Underperform | $18 → $9 | $9.51 | -5.36% | 2 | Jul 9, 2025 | |
| TFX Teleflex | Downgrades: Underperform | $235 → $140 | $103.40 | +35.40% | 5 | Mar 4, 2025 | |
| BLCO Bausch + Lomb | Maintains: Underperform | $18 → $17 | $16.98 | +0.12% | 3 | Feb 20, 2025 | |
| IART Integra LifeSciences Holdings | Maintains: Underperform | $26 → $18 | $11.90 | +51.26% | 13 | Oct 7, 2024 | |
| ITGR Integer Holdings | Maintains: Buy | $135 → $145 | $86.23 | +68.15% | 3 | Oct 1, 2024 | |
| MMSI Merit Medical Systems | Maintains: Neutral | $92 → $103 | $81.66 | +26.13% | 3 | Sep 16, 2024 | |
| HAE Haemonetics | Initiates: Neutral | $85 | $68.82 | +23.51% | 1 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $95 | $81.29 | +16.87% | 1 | Oct 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $43 → $36 | $16.80 | +114.29% | 2 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $23 → $45 | $9.17 | +390.73% | 3 | May 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $120 | $8.71 | +1,277.73% | 2 | Mar 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $30 | $7.47 | +301.61% | 5 | Mar 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $17 → $13 | $23.04 | -43.58% | 2 | Mar 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $48 → $42 | $13.33 | +215.08% | 3 | Feb 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $207 → $230 | $523.99 | -56.11% | 1 | Jan 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $190 → $230 | $355.04 | -35.22% | 4 | Jul 26, 2019 |
GE HealthCare Technologies
Jan 5, 2026
Maintains: Neutral
Price Target: $82 → $92
Current: $79.77
Upside: +15.33%
PROCEPT BioRobotics
Dec 8, 2025
Downgrades: Neutral
Price Target: $55 → $38
Current: $29.13
Upside: +30.45%
Globus Medical
Nov 7, 2025
Upgrades: Buy
Price Target: $65 → $91
Current: $92.52
Upside: -1.64%
RxSight
Jul 9, 2025
Maintains: Underperform
Price Target: $18 → $9
Current: $9.51
Upside: -5.36%
Teleflex
Mar 4, 2025
Downgrades: Underperform
Price Target: $235 → $140
Current: $103.40
Upside: +35.40%
Bausch + Lomb
Feb 20, 2025
Maintains: Underperform
Price Target: $18 → $17
Current: $16.98
Upside: +0.12%
Integra LifeSciences Holdings
Oct 7, 2024
Maintains: Underperform
Price Target: $26 → $18
Current: $11.90
Upside: +51.26%
Integer Holdings
Oct 1, 2024
Maintains: Buy
Price Target: $135 → $145
Current: $86.23
Upside: +68.15%
Merit Medical Systems
Sep 16, 2024
Maintains: Neutral
Price Target: $92 → $103
Current: $81.66
Upside: +26.13%
Haemonetics
Sep 11, 2024
Initiates: Neutral
Price Target: $85
Current: $68.82
Upside: +23.51%
Oct 30, 2023
Initiates: Buy
Price Target: $95
Current: $81.29
Upside: +16.87%
Jan 18, 2022
Maintains: Buy
Price Target: $43 → $36
Current: $16.80
Upside: +114.29%
May 13, 2020
Reiterates: Overweight
Price Target: $23 → $45
Current: $9.17
Upside: +390.73%
Mar 25, 2020
Maintains: Overweight
Price Target: $15 → $120
Current: $8.71
Upside: +1,277.73%
Mar 24, 2020
Maintains: Neutral
Price Target: $60 → $30
Current: $7.47
Upside: +301.61%
Mar 24, 2020
Reiterates: Overweight
Price Target: $17 → $13
Current: $23.04
Upside: -43.58%
Feb 25, 2020
Maintains: Neutral
Price Target: $48 → $42
Current: $13.33
Upside: +215.08%
Jan 10, 2020
Reiterates: Overweight
Price Target: $207 → $230
Current: $523.99
Upside: -56.11%
Jul 26, 2019
Maintains: Neutral
Price Target: $190 → $230
Current: $355.04
Upside: -35.22%